Androgens and cardiovascular disease in postmenopausal women: a systematic review

References

• Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27: 994–1005
   PubMed Web of Science ®Google Scholar
• Rosano GM, Maffei S, Andreassi MG, et al. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med (Hagerstown) 2009;10:85–92
   PubMed Web of Science ®Google Scholar
• Doumas M, Papademetriou V, Faselis C, Kokkinos P. Gender differences in hypertension: myths and reality. Curr Hypertens Rep 2013;15:321–30
   PubMed Web of Science ®Google Scholar
• Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6:532–42
   PubMed Web of Science ®Google Scholar
• Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, Rosano GM. Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med (Hagerstown) 2010;11:207–20
   PubMed Web of Science ®Google Scholar
• Spoletini I, Vitale C, Malorni W, Rosano GM. Sex differences in drug effects: interaction with sex hormones in adult life. Handb Exp Pharmacol 2012:91–105
   PubMedGoogle Scholar
• Franconi F, Carru C, Spoletini I, et al. A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics. Ther Deliv 2012;2:1437–53
   Google Scholar
• Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2012;97:870–5
   Web of Science ®Google Scholar
• Spoletini I, Caprio M, Vitale C, Rosano GM. Androgens and cardiovascular disease: Gender-related differences. Menopause Int 2013;19:82–6
   PubMedGoogle Scholar
• Akishita M, Yu J. Hormonal effects on blood vessels. Hypertens Res 2012;35:363–9
   PubMed Web of Science ®Google Scholar
• Montalcini T, Migliaccio V, Ferro Y, Gazzaruso C, Pujia A. Androgens for postmenopausal women’s health?Endocrine 2012;42:514–20
   PubMed Web of Science ®Google Scholar
• Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96:1642–53
   PubMed Web of Science ®Google Scholar
• Panay N, Al-Azzawi F, Bouchard C, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010;13:121–31
   PubMed Web of Science ®Google Scholar
• Davis SR, Worsley R. Androgen treatment of postmenopausal women. J Steroid Biochem Mol Biol 2013 May 29. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227–36
   PubMed Web of Science ®Google Scholar
• Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529–37
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Pines A, Archer DF, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
   PubMed Web of Science ®Google Scholar
• Brand JS, van der Schouw YT. Testosterone, SHBG and cardiovascular health in postmenopausal women. Int J Impot Res 2010;22:91–104
   PubMed Web of Science ®Google Scholar
• Goh HH, Loke DF, Ratnam SS. The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women. Maturitas 1995;21:65–70
   PubMed Web of Science ®Google Scholar
• Naessen T, Bergquist J, Lind L, Kushnir MM. Higher endogenous estrogen levels in 70-year-old women and men: an endogenous response to counteract developing atherosclerosis?Menopause 2012;19:1322–8
   PubMed Web of Science ®Google Scholar
• English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000;21:890–4
   PubMed Web of Science ®Google Scholar
• Rosano GM, Sheiban I, Massaro R, et al. Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 2007;19:176–82
   PubMed Web of Science ®Google Scholar
• Jones RD, Hugh Jones T, Channer KS. The influence of testosterone upon vascular reactivity. Eur J Endocrinol 2004;151:29–37
   PubMed Web of Science ®Google Scholar
• Bernini GP, Sgro M, Moretti A, et al. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 1999;84:2008–12
   PubMed Web of Science ®Google Scholar
• Rosano GM, Cornoldi A, Fini M. Effects of androgens on the cardiovascular system. J Endocrinol Invest 2005;28:32–8
   PubMedGoogle Scholar
• Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–53
   PubMed Web of Science ®Google Scholar
• Golden SH, Maguire A, Ding J, et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 2002;155:437–45
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995;311:1193–6
   PubMed Web of Science ®Google Scholar
• Phillips GB, Pinkernell BH, Jing TY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 1997;17:695–701
   PubMed Web of Science ®Google Scholar
• Pappa T, Alevizaki M. Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period. Eur J Endocrinol 2012;167:145–56
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab 2010;95:740–7
   PubMed Web of Science ®Google Scholar
• Sievers C, Klotsche J, Pieper L, et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol 2010;163:699–708
   PubMed Web of Science ®Google Scholar
• Scarabin-Carre V, Canonico M, Brailly-Tabard S, et al. High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study. J Am Heart Assoc 2012;1:e001388
   Google Scholar
• Rexrode KM, Manson JE, Lee IM, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003;108:1688–93
   PubMed Web of Science ®Google Scholar
• Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009;94:4776–84
   PubMed Web of Science ®Google Scholar
• Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis 2007;18:9–13
   PubMed Web of Science ®Google Scholar
• Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008;57:961–5
   PubMed Web of Science ®Google Scholar
• Golden SH, Dobs AS, Vaidya D, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007;92:1289–95
   PubMed Web of Science ®Google Scholar
• Haffner SM, Newcomb PA, Marcus PM, Klein BE, Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 1995;142:925–34
   PubMed Web of Science ®Google Scholar
• Saltiki K, Cimponeriu A, Garofalaki M, et al. Severity of coronary artery disease in postmenopausal women: association with the androgen receptor gene (CAG)n repeat polymorphism. Menopause 2011;18:1225–31
   PubMed Web of Science ®Google Scholar
• Alevizaki M, Saltiki K, Xita N, et al. The importance of the (TAAAA)n alleles at the SHBG gene promoter for the severity of coronary artery disease in postmenopausal women. Menopause 2008;15:461–8
   PubMed Web of Science ®Google Scholar
• Leao LM, Duarte MP, Silva DM, Bahia PR, Coeli CM, de Farias ML. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study. Eur J Endocrinol 2006;154:131–9
   PubMed Web of Science ®Google Scholar
• Chiuve SE, Martin LA, Campos H, Sacks FM. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. J Clin Endocrinol Metab 2004;89:2207–13
   PubMed Web of Science ®Google Scholar
• Basaria S, Nguyen T, Rosenson RS, Dobs AS. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf) 2002;57:209–14
   PubMed Web of Science ®Google Scholar
• Dobs AS, Nguyen T, Pace C, Roberts CP. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002;87:1509–16
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Young R, Notelovitz M, et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999;44:1012–20
   PubMed Web of Science ®Google Scholar
• Raisz LG, Wiita B, Artis A, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996;81:37–43
   PubMed Web of Science ®Google Scholar
• Davis SR, Walker KZ, Strauss BJ. Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women. Menopause 2000;7:395–401
   PubMed Web of Science ®Google Scholar
• Gruber DM, Sator MO, Kirchengast S, Joura EA, Huber JC. Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women. Maturitas 1998;29:253–9
   PubMed Web of Science ®Google Scholar
• Britto R, Araujo L, Barbosa I, Silva L. Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants. Gynecol Endocrinol 2012;28:767–9
   PubMed Web of Science ®Google Scholar
• Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005–17
   PubMed Web of Science ®Google Scholar
• Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582–9
   PubMed Web of Science ®Google Scholar
• Nachtigall L, Casson P, Lucas J, Schofield V, Melson C, Simon JA. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecol Endocrinol 2011;27:39–48
   PubMed Web of Science ®Google Scholar
• Zang H, Carlstrom K, Arner P, Hirschberg AL. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 2006;86:136–44
   PubMed Web of Science ®Google Scholar
• Caminiti G, Karam R, Volterrani M, et al. Clinical and metabolic effects of six months testosterone treatment in elderly female patients with chronic heart failure. Circulation 2009;118:S711–12
   Google Scholar
• Iellamo F, Volterrani M, Caminiti G, et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol 2010;56:1310–16
   PubMed Web of Science ®Google Scholar
• Schwartz JB, Volterrani M, Caminiti G, et al. Effects of testosterone on the Q-T interval in older men and older women with chronic heart failure. Int J Androl 2011;34:e415–21
   Google Scholar
• Machinal-Quelin F, Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 2002;18:179–84
   PubMed Web of Science ®Google Scholar
• Williams MR, Dawood T, Ling S, et al. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 2004;89:4708–15
   PubMed Web of Science ®Google Scholar
• Basaria S, Dobs AS. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women. J Clin Endocrinol Metab 2006;91:4743–52
   PubMed Web of Science ®Google Scholar
• Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 2001;86:158–61
   PubMed Web of Science ®Google Scholar
• Matsui S, Yasui T, Tani A, et al. Associations of estrogen and testosterone with insulin resistance in pre- and postmenopausal women with and without hormone therapy. Int J Endocrinol Metab 2010;11:65–70
   Google Scholar
• Weiss EP, Villareal DT, Ehsani AA, Fontana L, Holloszy JO. Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness. Aging Cell 2012;11:876–84
   PubMed Web of Science ®Google Scholar
• Kocoska-Maras L, Hirschberg AL, Bystrom B, Schoultz BV, Radestad AF. Testosterone addition to estrogen therapy – effects on inflammatory markers for cardiovascular disease. Gynecol Endocrinol 2009;25:823–7
   PubMed Web of Science ®Google Scholar
• Matthews KA, Owens JF, Salomon K, Harris KF, Berga SL. Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women. Biol Psychol 2005;69:39–56
   PubMed Web of Science ®Google Scholar
• Dayal M, Sammel MD, Zhao J, Hummel AC, Vandenbourne K, Barnhart KT. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids. J Womens Health (Larchmt) 2005;14:391–400
   PubMed Web of Science ®Google Scholar
• Warnock JK, Swanson SG, Borel RW, Zipfel LM, Brennan JJ. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Menopause 2005;12:374–84
   PubMed Web of Science ®Google Scholar
• Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79:1341–52
   PubMed Web of Science ®Google Scholar
• Penotti M, Sironi L, Cannata L, et al. Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries. Fertil Steril 2001;76:235–40
   PubMed Web of Science ®Google Scholar
• Casson PR, Faquin LC, Stentz FB, et al. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 1995;63:1027–31
   PubMed Web of Science ®Google Scholar
• Hickok LR, Toomey C, Speroff L. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. Obstet Gynecol 1993;82:919–24
   PubMed Web of Science ®Google Scholar
• Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990;71:696–704
   PubMed Web of Science ®Google Scholar